Arkea Bio Corp. research brief
CIK 2004801
Generated Nov. 2, 2026, 2:50 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: CHARLESTOWN MA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 9, 2026 · D · 0002004801-26-000001 · Source evidence
Reported offering amount: 32999992 USD. Reported amount sold: 14999995 USD.
- Oct. 14, 2025 · D · 0002004801-25-000002 · Source evidence
Reported offering amount: 12000017 USD. Reported amount sold: 6999999 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Arkea Bio Corp. research brief,” CIK 2004801, retrieved Nov. 2, 2026, 2:50 p.m.. Cite the specific accessions used. No amounts have been summed.